Japanese subgroup analysis of a phase III study of S-1 versus docetaxel in non-small cell lung cancer patients after platinum-based treatment: EAST-LC.
Saved in:
| Title: | Japanese subgroup analysis of a phase III study of S-1 versus docetaxel in non-small cell lung cancer patients after platinum-based treatment: EAST-LC. |
|---|---|
| Authors: | Sugawara S; Department of Pulmonary Medicine, Sendai Kousei Hospital, Miyagi, Japan., Nakagawa K; Department of Medical Oncology, Faculty of Medicine, Kindai University, Osaka, Japan., Yamamoto N; Third Department of Internal Medicine, Wakayama Medical University, Wakayama, Japan., Nokihara H; Department of Thoracic Oncology, National Cancer Center Hospital, Tokyo, Japan., Ohe Y; Department of Thoracic Oncology, National Cancer Center Hospital, Tokyo, Japan., Nishio M; Department of Thoracic Medical Oncology, The Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan., Takahashi T; Division of Thoracic Oncology, Shizuoka Cancer Center, Shizuoka, Japan., Goto K; Department of Thoracic Oncology, National Cancer Center Hospital East, Kashiwa, Japan., Maemondo M; Department of Respiratory Medicine, Miyagi Cancer Center, Miyagi, Japan., Ichinose Y; Department of Cancer Information Research, National Kyushu Cancer Center, Clinical Research Institute, Fukuoka, Japan., Seto T; Department of Thoracic Oncology, National Kyushu Cancer Center, Fukuoka, Japan., Sakai H; Department of Thoracic Oncology, Saitama Cancer Center, Saitama, Japan., Gemma A; Department of Pulmonary Medicine and Oncology, Graduate School of Medicine, Nippon Medical School, Tokyo, Japan., Imamura F; Department of Thoracic Oncology, Osaka International Cancer Institute, Osaka, Japan., Shingyoji M; Division of Respirology, Chiba Cancer Center, Chiba, Japan., Saka H; Department of Respiratory Medicine and Medical Oncology, National Hospital Organization Nagoya Medical Center, Aichi, Japan., Inoue A; Department of Palliative Medicine, Tohoku University School of Medicine, Miyagi, Japan., Takeda K; Department of Medical Oncology, Osaka City General Hospital, Osaka, Japan., Okamoto I; Research Institute for Diseases of the Chest, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan., Kiura K; Department of Hematology, Oncology, and Respiratory Medicine, Okayama University Graduate School of Medicine, Okayama, Japan., Morita S; Department of Biomedical Statistics and Bioinformatics, Kyoto University Graduate School of Medicine, Kyoto, Japan., Tamura T; Thoracic Center, St Luke's International Hospital, 9-1 Akashi-cho, Chuo-ku, Tokyo, 104-8560, Japan. tamuratomohide@gmail.com. |
| Source: | International journal of clinical oncology [Int J Clin Oncol] 2019 May; Vol. 24 (5), pp. 485-493. Date of Electronic Publication: 2019 Mar 04. |
| Publication Type: | Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial |
| Journal Info: | Publisher: Springer-Verlag Tokyo Country of Publication: Japan NLM ID: 9616295 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1437-7772 (Electronic) Linking ISSN: 13419625 NLM ISO Abbreviation: Int J Clin Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 30830659 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Japanese subgroup analysis of a phase III study of S-1 versus docetaxel in non-small cell lung cancer patients after platinum-based treatment: EAST-LC. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Sugawara+S%22">Sugawara S</searchLink>; Department of Pulmonary Medicine, Sendai Kousei Hospital, Miyagi, Japan.<br /><searchLink fieldCode="AU" term="%22Nakagawa+K%22">Nakagawa K</searchLink>; Department of Medical Oncology, Faculty of Medicine, Kindai University, Osaka, Japan.<br /><searchLink fieldCode="AU" term="%22Yamamoto+N%22">Yamamoto N</searchLink>; Third Department of Internal Medicine, Wakayama Medical University, Wakayama, Japan.<br /><searchLink fieldCode="AU" term="%22Nokihara+H%22">Nokihara H</searchLink>; Department of Thoracic Oncology, National Cancer Center Hospital, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Ohe+Y%22">Ohe Y</searchLink>; Department of Thoracic Oncology, National Cancer Center Hospital, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Nishio+M%22">Nishio M</searchLink>; Department of Thoracic Medical Oncology, The Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Takahashi+T%22">Takahashi T</searchLink>; Division of Thoracic Oncology, Shizuoka Cancer Center, Shizuoka, Japan.<br /><searchLink fieldCode="AU" term="%22Goto+K%22">Goto K</searchLink>; Department of Thoracic Oncology, National Cancer Center Hospital East, Kashiwa, Japan.<br /><searchLink fieldCode="AU" term="%22Maemondo+M%22">Maemondo M</searchLink>; Department of Respiratory Medicine, Miyagi Cancer Center, Miyagi, Japan.<br /><searchLink fieldCode="AU" term="%22Ichinose+Y%22">Ichinose Y</searchLink>; Department of Cancer Information Research, National Kyushu Cancer Center, Clinical Research Institute, Fukuoka, Japan.<br /><searchLink fieldCode="AU" term="%22Seto+T%22">Seto T</searchLink>; Department of Thoracic Oncology, National Kyushu Cancer Center, Fukuoka, Japan.<br /><searchLink fieldCode="AU" term="%22Sakai+H%22">Sakai H</searchLink>; Department of Thoracic Oncology, Saitama Cancer Center, Saitama, Japan.<br /><searchLink fieldCode="AU" term="%22Gemma+A%22">Gemma A</searchLink>; Department of Pulmonary Medicine and Oncology, Graduate School of Medicine, Nippon Medical School, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Imamura+F%22">Imamura F</searchLink>; Department of Thoracic Oncology, Osaka International Cancer Institute, Osaka, Japan.<br /><searchLink fieldCode="AU" term="%22Shingyoji+M%22">Shingyoji M</searchLink>; Division of Respirology, Chiba Cancer Center, Chiba, Japan.<br /><searchLink fieldCode="AU" term="%22Saka+H%22">Saka H</searchLink>; Department of Respiratory Medicine and Medical Oncology, National Hospital Organization Nagoya Medical Center, Aichi, Japan.<br /><searchLink fieldCode="AU" term="%22Inoue+A%22">Inoue A</searchLink>; Department of Palliative Medicine, Tohoku University School of Medicine, Miyagi, Japan.<br /><searchLink fieldCode="AU" term="%22Takeda+K%22">Takeda K</searchLink>; Department of Medical Oncology, Osaka City General Hospital, Osaka, Japan.<br /><searchLink fieldCode="AU" term="%22Okamoto+I%22">Okamoto I</searchLink>; Research Institute for Diseases of the Chest, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.<br /><searchLink fieldCode="AU" term="%22Kiura+K%22">Kiura K</searchLink>; Department of Hematology, Oncology, and Respiratory Medicine, Okayama University Graduate School of Medicine, Okayama, Japan.<br /><searchLink fieldCode="AU" term="%22Morita+S%22">Morita S</searchLink>; Department of Biomedical Statistics and Bioinformatics, Kyoto University Graduate School of Medicine, Kyoto, Japan.<br /><searchLink fieldCode="AU" term="%22Tamura+T%22">Tamura T</searchLink>; Thoracic Center, St Luke's International Hospital, 9-1 Akashi-cho, Chuo-ku, Tokyo, 104-8560, Japan. tamuratomohide@gmail.com. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%229616295%22">International journal of clinical oncology</searchLink> [Int J Clin Oncol] 2019 May; Vol. 24 (5), pp. 485-493. <i>Date of Electronic Publication: </i>2019 Mar 04. – Name: TypePub Label: Publication Type Group: TypPub Data: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer-Verlag+Tokyo%22">Springer-Verlag Tokyo </searchLink><i>Country of Publication: </i>Japan <i>NLM ID: </i>9616295 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1437-7772 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2213419625%22">13419625 </searchLink><i>NLM ISO Abbreviation: </i>Int J Clin Oncol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=30830659 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1007/s10147-019-01396-z Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 485 Titles: – TitleFull: Japanese subgroup analysis of a phase III study of S-1 versus docetaxel in non-small cell lung cancer patients after platinum-based treatment: EAST-LC. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Sugawara S – PersonEntity: Name: NameFull: Nakagawa K – PersonEntity: Name: NameFull: Yamamoto N – PersonEntity: Name: NameFull: Nokihara H – PersonEntity: Name: NameFull: Ohe Y – PersonEntity: Name: NameFull: Nishio M – PersonEntity: Name: NameFull: Takahashi T – PersonEntity: Name: NameFull: Goto K – PersonEntity: Name: NameFull: Maemondo M – PersonEntity: Name: NameFull: Ichinose Y – PersonEntity: Name: NameFull: Seto T – PersonEntity: Name: NameFull: Sakai H – PersonEntity: Name: NameFull: Gemma A – PersonEntity: Name: NameFull: Imamura F – PersonEntity: Name: NameFull: Shingyoji M – PersonEntity: Name: NameFull: Saka H – PersonEntity: Name: NameFull: Inoue A – PersonEntity: Name: NameFull: Takeda K – PersonEntity: Name: NameFull: Okamoto I – PersonEntity: Name: NameFull: Kiura K – PersonEntity: Name: NameFull: Morita S – PersonEntity: Name: NameFull: Tamura T IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 05 Text: 2019 May Type: published Y: 2019 Identifiers: – Type: issn-electronic Value: 1437-7772 Numbering: – Type: volume Value: 24 – Type: issue Value: 5 Titles: – TitleFull: International journal of clinical oncology Type: main |
| ResultId | 1 |
